Kesha Buster is a Dermatology physician. OpenAlex indexes 8 publications with 862 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Arcutis Biotherapeutics, Inc.Program year20251 payment
- ABBVIE INC.Program year20241 payment
- MAYNE PHARMA COMMERCIAL LLCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
51.4%Azole Antifungal51.4%Ketoconazole100%Part D≥11 patientsCardiovascular
48.6%Arteriolar Vasodilator48.6%Minoxidil100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Photoprotection in specific populations: Children and people of color
Journal of the American Academy of Dermatology
2016 - Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public
Journal of the American Academy of Dermatology
2014 - Reply to ‘Skin cancer, photoprotection, and skin of color’
Journal of the American Academy of Dermatology
2014 - Sclerema neonatorum treated with intravenous immunoglobulin: a case report and review of treatments.
PubMed
2013
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Bridget Grant, MD
Bassett Medical Center
Robert Modlin, MD
University of California, Los Angeles
Andrew Blauvelt, MD
University of Maryland School of Medicine
Howard Maibach, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”